review article | Q7318358 |
scholarly article | Q13442814 |
P2093 | author name string | Li-Ping Liu | |
Da Lu | |||
Hui-Hong Zhang | |||
Yu-Ying Zhou | |||
Yong-Ming Zou | |||
P2860 | cites work | The Pocket Smell Test: successfully discriminating probable Alzheimer's dementia from vascular dementia and major depression. | Q51957423 |
Olfactory deficits in patients with mild cognitive impairment predict Alzheimer's disease at follow-up. | Q51974478 | ||
Age-associated memory impairment diagnoses: problems of reliability and concerns for terminology. | Q52047340 | ||
The nature and course of olfactory deficits in Alzheimer's disease. | Q52051585 | ||
Olfactory-evoked regional cerebral blood flow in Alzheimer's disease. | Q52067635 | ||
Presence of both odor identification and detection deficits in Alzheimer's disease. | Q53193962 | ||
The cholinergic deficit coincides with Abeta deposition at the earliest histopathologic stages of Alzheimer disease. | Q53234222 | ||
Olfaction in patients with mild cognitive impairment and Alzheimer's disease. | Q53284084 | ||
Follow-up study of olfactory deficits, cognitive functions, and volume loss of medial temporal lobe structures in patients with mild cognitive impairment. | Q53319207 | ||
Clinical observations of impaired cranial nerve function in senile dementia | Q68897886 | ||
Neuropathological stageing of Alzheimer-related changes | Q27860862 | ||
Olfaction and Aging: A Mini-Review | Q28082742 | ||
The olfactory system and its disorders | Q28235141 | ||
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria | Q30458193 | ||
Smell identification function and Alzheimer's disease: a selective review | Q30884681 | ||
Olfactory impairment in presymptomatic Alzheimer's disease | Q33802937 | ||
The lateralized smell test for detecting Alzheimer's disease: failure to replicate | Q34204304 | ||
Smell identification ability: changes with age. | Q34262491 | ||
Olfactory function in corticobasal syndrome and frontotemporal dementia | Q34330732 | ||
A brief olfactory test for Alzheimer's disease | Q34362755 | ||
Olfactory deficits predict cognitive decline and Alzheimer dementia in an urban community | Q34451903 | ||
Sexual dimorphism in the human olfactory bulb: females have more neurons and glial cells than males | Q34456782 | ||
Prevalence of olfactory impairment in older adults | Q34528835 | ||
The brain structural and cognitive basis of odor identification deficits in mild cognitive impairment and Alzheimer's disease | Q34538738 | ||
Olfactory tau pathology in Alzheimer disease and mild cognitive impairment. | Q34586398 | ||
Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease | Q34988061 | ||
Olfaction in neurologic and neurodegenerative diseases: a literature review. | Q35440895 | ||
The relationship between cerebral Alzheimer's disease pathology and odour identification in old age. | Q36227293 | ||
Olfactory deficit detected by fMRI in early Alzheimer's disease | Q36449520 | ||
Olfactory dysfunction as a predictor of neurodegenerative disease | Q36575007 | ||
Olfaction and apathy in Alzheimer's disease, mild cognitive impairment, and healthy older adults | Q36877753 | ||
Combining early markers strongly predicts conversion from mild cognitive impairment to Alzheimer's disease | Q37036765 | ||
The human olfactory mucosa | Q37588540 | ||
Awareness of olfactory deficits in healthy aging, amnestic mild cognitive impairment and Alzheimer's disease. | Q37830801 | ||
Olfactory identification testing as a predictor of the development of Alzheimer's dementia: a systematic review | Q38007110 | ||
Olfactory dysfunction in Parkinson disease | Q38009992 | ||
Distinct patterns of olfactory impairment in Alzheimer's disease, semantic dementia, frontotemporal dementia, and corticobasal degeneration | Q38399840 | ||
Odor identification in normal aging and early Alzheimer's disease: effects of retrieval support | Q38450521 | ||
Olfactory impairment and subjective olfactory complaints independently predict conversion to dementia: a longitudinal, population-based study. | Q39266938 | ||
Odor identification and self-reported olfactory functioning in patients with subtypes of mild cognitive impairment | Q40002811 | ||
Olfactory deficits and amyloid-β burden in Alzheimer's disease, mild cognitive impairment, and healthy aging: a PiB PET study | Q42866937 | ||
Functional representation of olfactory impairment in early Alzheimer's disease | Q42905336 | ||
Number of people in UK with dementia will more than double by 2050. | Q42942591 | ||
Odor identification deficit predicts clinical conversion from mild cognitive impairment to dementia due to Alzheimer's disease | Q44131513 | ||
ERP, fMRI and functional connectivity studies of brain response to odor in normal aging and Alzheimer's disease | Q44394442 | ||
Smell identification test as a treatment response marker in patients with Alzheimer disease receiving donepezil. | Q45932118 | ||
Smell identification function as a severity and progression marker in Alzheimer's disease. | Q46014314 | ||
Left hippocampal volume loss in Alzheimer's disease is reflected in performance on odor identification: a structural MRI study | Q46868371 | ||
Early olfactory involvement in Alzheimer's disease. | Q48373191 | ||
The effect of Alzheimer's disease and Parkinson's disease on olfaction: a meta-analysis | Q48616725 | ||
P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
P6216 | copyright status | copyrighted | Q50423863 |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Alzheimer's disease | Q11081 |
olfaction disorder | Q11419348 | ||
P304 | page(s) | 869-75 | |
P577 | publication date | 2016-01-01 | |
P1433 | published in | Neuropsychiatric Disease and Treatment | Q15716332 |
P1476 | title | Olfactory dysfunction in Alzheimer's disease | |
P478 | volume | 12 |
Q47836378 | A Novel Early Diagnosis System for Mild Cognitive Impairment Based on Local Region Analysis: A Pilot Study. |
Q64063621 | Anatomical basis and physiological role of cerebrospinal fluid transport through the murine cribriform plate |
Q36195000 | Assessment of Olfactory Function in MAPT-Associated Neurodegenerative Disease Reveals Odor-Identification Irreproducibility as a Non-Disease-Specific, General Characteristic of Olfactory Dysfunction |
Q98290450 | Auditory and Olfactory Deficits in Essential Tremor - Review of the Current Evidence |
Q52558378 | Bioactive Bromotyrosine-Derived Alkaloids from the Polynesian Sponge Suberea ianthelliformis. |
Q99573904 | Endocrine stress responsivity and social memory in 3xTg-AD female and male mice: A tale of two experiments |
Q97533478 | Longitudinal profiling of oligomeric Aβ in human nasal discharge reflecting cognitive decline in probable Alzheimer's disease |
Q59791740 | Loss of Ca/Calmodulin Dependent Protein Kinase Kinase 2 Leads to Aberrant Transferrin Phosphorylation and Trafficking: A Potential Biomarker for Alzheimer's Disease |
Q92491787 | Mechanisms of tissue and cell-type specificity in heritable traits and diseases |
Q55441236 | Non-linear ICA Analysis of Resting-State fMRI in Mild Cognitive Impairment. |
Q36159543 | Olfactory Dysfunction Is Associated with the Intake of Macronutrients in Korean Adults |
Q64866924 | Olfactory Dysfunction in Neurodegenerative Diseases |
Q57126675 | Olfactory function and neurocognitive outcomes in old age: The Atherosclerosis Risk in Communities Neurocognitive Study |
Q64976482 | Polymorphisms in the Cholinergic Receptors Muscarinic (CHRM2 and CHRM3) Genes and Alzheimer's Disease. |
Q47865513 | Relationships Between Lower Olfaction and Brain White Matter Lesions in Elderly Subjects with Mild Cognitive Impairment. |
Q42516901 | Role of serum albumin as a nanoparticulate carrier for nose-to-brain delivery of R-flurbiprofen: implications for the treatment of Alzheimer's disease. |
Q92694953 | Sensory Overload? Air Pollution and Impaired Olfaction |
Q52598834 | Tau Proteolysis in the Pathogenesis of Tauopathies: Neurotoxic Fragments and Novel Biomarkers. |
Q92562491 | The formyl peptide receptor agonist FPRa14 induces differentiation of Neuro2a mouse neuroblastoma cells into multiple distinct morphologies which can be specifically inhibited with FPR antagonists and FPR knockdown using siRNA |
Q50535209 | Toxoplasma gondii alters NMDAR signaling and induces signs of Alzheimer's disease in wild-type, C57BL/6 mice. |
Q56975629 | Using Multi-Scale Genetic, Neuroimaging and Clinical Data for Predicting Alzheimer's Disease and Reconstruction of Relevant Biological Mechanisms |
Q90699563 | Validity and Reliability of Persian Smell Identification Test |
Q52682109 | Visualization of Altered Hippocampal Connectivity in an Animal Model of Alzheimer's Disease. |